Category Archives: Bisphosphonates

Featured Stories
Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Three Injured, Long Island Railroad Train Hits Car on Tracks

Three Injured When Long Island Railroad Train Hits Car on Tracks

Three people, including a train engineer, were injured on Wednesday when a Long Island Rail Road train hit a livery cab on the tracks west of Wyandanch station, LIRR officials said. LIRR spokesman Salvatore Arena said the driver of the Lincoln Town Car was taken to Good Samaritan Hospital Medical Center ...

Read More

Pradaxa not Fit for a Dog, Family of Alleged Pradaxa Bleeding Victim Claims

The family of a Texas woman who died just months before her 60th wedding anniversary believes she would be alive today were it not for Pradaxa (dabigatran). According to a report from the Houston Press, Pradaxa patient Loraine Franklin fell and hit her head last December, resulting in an intracranial ...

Read More

Cancer Groups Issue Statement for Regulation of E-cigarettes

Cancer Groups Issue Statement Calling for Research and Regulation of E-cigarettes

The American Society of Clinical Oncology & the American Association for Cancer Research are calling on the government to regulate e-cigarettes.

Read More

Crash on N.State Pkwy Kills Port Jefferson Station Man

Single-Car Crash on Northern State Parkway Kills Port Jefferson Station Man

81-year-old Port Jefferson Station man was killed in a crash at 4:57 a.m.. He lost control of the vehicle traveling west on Northern State Pkwy, on exit 42, Dix Hills.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

FDA Gives 7 Companies Go Ahead To Market Generic Plavix

The U.S. Food & Drug Administration (FDA) just gave seven companies the go-ahead to market generic Plavix. Plavix is a blood thinner prescribed for the prevention of blood clots, heart attacks, and which has been linked to serious side effects such as the heart attacks and strokes it is supposed to ...

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

Conflicting Studies on Oral Bisphosphonates, Esophageal Cancer Yield Confusion

Federal drug regulators in the U.S. are currently reviewing two conflicting studies examining a possible association between oral bisphosphonates, like Fosamax, and esophageal cancer. According to a report in The Wall Street Journal, it’s difficult to discern which of the … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Long-Term Fosamax Use May Raise Esophageal Cancer Risk

Oral bisphosphonates, including Fosamax, may increase risks for esophageal cancer if they are used for longer than 5 years. In September 2010, a study published in the British Medical Journal found that people who had taken the oral bisphosphonates over … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Eye Disorders Another Possible Bisphosphonate Side Effect

Fosamax and other bisphosphonates used by millions of women to prevent osteoporosis may make it more likely that they will suffer anterior uveitis and scleritis, serious inflammatory eye disorders. Uveitis is inflammation of the middle layer of the eye, which … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals |

Bisphosphonate Litigation Moving Forward, As FDA Approves Generic Boniva

The U.S. Food and Drug Administration (FDA) this week approved the first generic versions of the bisphosphonate, ibandronate (Boniva). The announcement comes just as litigation involving bisphosphonate side effect lawsuits is heating up in both state and federal courts. Ibandronate … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

National Law Firm Files 36 Fosamax Femur Fracture Lawsuits

Earlier this month, the national law firm of Parker Waichman LLP filed 36 Fosamax femur fracture lawsuits in the Fosamax side effects mass tort currently underway in New Jersey Superior Court. All of the lawsuits allege that the long-term use … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals |

Stopping Bisphosphonates May Reduce Femur Fracture Risk

Stopping bisphosphonates, a class of osteoporosis drugs that builds bone, could reduce risks for femur fracture by half, according to growing research. The rare, but serious, thigh bone fracture, known as atypical femur fracture, has been linked to oral bisphosphonates … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Judge Refuses To Overturn Zometa Dead Jaw Verdict

A federal judge has refused to overturn a verdict Zometa dead jaw lawsuit. Previously, a jury agreed that the drug maker neglected to appropriately warn about the risks connected to its bone-strengthening medications, Zometa and Aredia, such as severe jaw … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Fosamax, Other Osteoporosis Drugs Need Stronger Warnings, FDA Advisors Say

A panel of Food & Drug Administration (FDA) advisors said on Friday that < "http://www.yourlawyer.com/topics/overview/fosamax">Fosamax and similar bone drugs need stronger warnings regarding duration of use because of their possible long-term risks. But the panel could not agree if use … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals |

Five Years on Fosamax, Other Bone Drugs May be Adequate, FDA Says

< "http://www.yourlawyer.com/topics/overview/fosamax">Fosamax, < "http://www.yourlawyer.com/topics/overview/actonel">Actonel, < "http://www.yourlawyer.com/topics/overview/Boniva">Boniva and other oral bisphosphonates don’t have to be taken beyond five years in order to prevent broken bones from osteoporosis, a new U.S. Food & Drug Administration (FDA) report says. The report was released … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals |

FDA Panel to Discuss Long-Term Use of Fosamax, other Bone Drugs

A U.S. Food & Drug Administration (FDA) advisory panel is set to examine the safety of < "http://www.yourlawyer.com/topics/overview/Bisphosphonates">oral bisphosphonates later this week. The FDA advisory panel meeting, set to start of Friday, is being convened because of concerns that long-term … Continue reading

Posted in Bisphosphonates |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.